Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency

Nature Communications

Volumn 6, Issue , 2015, Pages

  Chen, Hongwei ^a,b   Aksoy, Irène ^a,b,c   Gonnot, Fabrice ^a,b   Osteil, Pierre ^a,b   Aubry, Maxime ^a,b   Hamela, Claire ^a,b   Rognard, Cloé ^a,b   Hochard, Arnaud ^a,b   Voisin, Sophie ^a,b,d   Fontaine, Emeline ^a,b   Mure, Magali ^a,b   Afanassieff, Marielle ^a,b,d   Cleroux, Elouan ^e   Guibert, Sylvain ^e   Chen, Jiaxuan ^c   Vallot, Céline ^f   Acloque, Hervé ^g   Genthon, Clémence ^g   Donnadieu, Cécile ^g   De Vos, John ^h,i   Sanlaville, Damien ^j   Guérin, Jean François ^a,b   Weber, Michael ^e   Stanton, Lawrence W ^c   Rougeulle, Claire ^f   Pain, Bertrand ^a,b,d   Bourillot, Pierre Yves ^a,b   Savatier, Pierre ^a,b   more..

^a STEM CELL AND BRAIN RESEARCH INSTITUTE   (France)

^b UNIVERSITÉ DE LYON   (France)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

^d CEMAGREF   (France)

^e UNIVERSITÉ DE STRASBOURG   (France)

^f CNRS   (France)

^g UMR1388 GenPhySE   (France)

^h INSERM   (France)

ⁱ HÔPITAL SAINT ELOI   (France)

^j LYON NEUROSCIENCE RESEARCH CENTER   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ACTIVIN; ACTIVIN RECEPTOR; CYTOCHROME P450 1B1; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; FIBROBLAST GROWTH FACTOR 2; GLYCOPROTEIN GP 130; HEPATOCYTE NUCLEAR FACTOR 3BETA; JANUS KINASE; KRUPPEL LIKE FACTOR 2; KRUPPEL LIKE FACTOR 4; KRUPPEL LIKE FACTOR 5; LEUKEMIA INHIBITORY FACTOR RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TAMOXIFEN; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR NKX2.5; LEUKEMIA INHIBITORY FACTOR; LIF PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN;

EMBRYO; ENZYME ACTIVITY; GENE EXPRESSION; GERM CELL; GROWTH RATE; HORMONE; LIGAND; SIGNALING;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL RENEWAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ECTODERM; EMBRYO; EMBRYONIC STEM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PREIMPLANTATION EMBRYO; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; DRUG EFFECTS; FEEDER CELL; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN MICROARRAY;

RODENTIA;

ANIMALS; EMBRYONIC STEM CELLS; FEEDER CELLS; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; LEUKEMIA INHIBITORY FACTOR; MICE; PLURIPOTENT STEM CELLS; PROTEIN ARRAY ANALYSIS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TAMOXIFEN;

EID: 84929359290     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8095     Document Type: Article

References (54)

1. Evans, M. J. & Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156 (1981).
2. Smith, A. G. et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336, 688-690 (1988).
3. Tesar, P. J. et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196-199 (2007).
4. Brons, I. G. et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191-195 (2007).
5. Ying, Q. L. et al. The ground state of embryonic stem cell self-renewal. Nature 453, 519-523 (2008).
6. Nichols, J., Silva, J., Roode, M. & Smith, A. Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo. Development 136, 3215-3232 (2009).
7. De Los Angeles, A., Loh, Y. H., Tesar, P. J. & Daley, G. Q. Accessing naive human pluripotency. Curr. Opin. Genet. Dev. 22, 272-282 (2012).
8. Vallier, L., Alexander, M. & Pedersen, R. A. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 118, 4495-4509 (2005).
9. Hanna, J. et al. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc. Natl Acad. Sci. USA 107, 9222-9227 (2010).
10. Gafni, O. et al. Derivation of novel human ground state naive pluripotent stem cells. Nature 504, 282-286 (2013).
11. Chan, Y. S. et al. Induction of a human pluripotent state with distinct regulatory circuitry that resembles preimplantation epiblast. Cell Stem Cell 13, 663-675 (2013).
12. Ware, C. B. et al. Derivation of naive human embryonic stem cells. Proc. Natl Acad. Sci. USA 111, 4484-4489 (2014).
13. Valamehr, B. et al. Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells. Stem Cell Rep. 2, 366-381 (2014).
14. Theunissen, T. W. et al. Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell 15, 471-487 (2014).
15. Takashima, Y. et al. Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell 158, 1254-1269 (2014).
16. Boeuf, H., Hauss, C., Graeve, F. D., Baran, N. & Kedinger, C. Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells. J. Cell Biol. 138, 1207-1217 (1997).
17. Niwa, H., Burdon, T., Chambers, I. & Smith, A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12, 2048-2060 (1998).
18. Burdon, T., Smith, A. & Savatier, P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell. Biol. 12, 432 (2002).
19. Bourillot, P. Y. et al. Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog. Stem Cells 27, 1760-1771 (2009).
20. Matsuda, T. et al. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 18, 4261-4269 (1999).
21. Aksoy, I. et al. Self-renewal of murine embryonic stem (ES) cells is supported by the serine/threonine kinases Pim-1 and Pim-3. Stem Cells 25, 2996-3004 (2007).
22. Ye, S., Li, P., Tong, C. & Ying, Q. L. Embryonic stem cell self-renewal pathways converge on the transcription factor Tfcp2l1. EMBO J. 32, 2548-2560 (2013).
23. Martello, G., Bertone, P. & Smith, A. Identification of the missing pluripotency mediator downstream of leukaemia inhibitory factor. EMBO J. 32, 2561-2574 (2013).
24. Guo, G. et al. Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 136, 1063-1069 (2009).
25. Yang, J. et al. Stat3 activation is limiting for reprogramming to ground state pluripotency. Cell Stem Cell 7, 319-328 (2010).
26. van Oosten, A. L., Costa, Y., Smith, A. & Silva, J. C. JAK/STAT3 signalling is sufficient and dominant over antagonistic cues for the establishment of naive pluripotency. Nat. Commun. 3, 817 (2012).
27. Daheron, L. et al. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells 22, 770-778 (2004).
28. Ema, M. et al. Kruppel-like factor 5 is essential for blastocyst development and the normal self-renewal of mouse ESCs. Cell Stem Cell 3, 555-567 (2008).
29. Parisi, S. et al. Klf5 is involved in self-renewal of mouse embryonic stem cells. J. Cell Sci. 121, 2629-2634 (2008).
30. Tai, C. I. & Ying, Q. L. Gbx2, a LIF/Stat3 target, promotes reprogramming to and retention of the pluripotent ground state. J. Cell Sci. 126, 1093-1098 (2013).
31. Aksoy, I. et al. Klf4 and Klf5 differentially inhibit mesoderm and endoderm differentiation in embryonic stem cells. Nat. Commun. 5, 3719-3733 (2014).
32. Li, Y. et al. Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 105, 635-637 (2005).
33. Niwa, H., Ogawa, K., Shimosato, D. & Adachi, K. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 460, 118-122 (2009).
34. Hall, J. et al. Oct4 and LIF/Stat3 additively induce Kruppel factors to sustain embryonic stem cell self-renewal. Cell Stem Cell 5, 597-609 (2009).
35. Stuart, H. T. et al. NANOG amplifies STAT3 activation and they synergistically induce the naive pluripotent program. Curr. Biol. 24, 340-346 (2014).
36. Burdon, T., Stracey, C., Chambers, I., Nichols, J. & Smith, A. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev. Biol. 210, 30-43 (1999).
37. Adewumi, O. et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 25, 803-816 (2007).
38. Leitch, H. G. et al. Naive pluripotency is associated with global DNA hypomethylation. Nat. Struct. Mol. Biol. 20, 311-316 (2013).
39. Ficz, G. et al. FGF signaling inhibition in ESCs drives rapid genome-wide demethylation to the epigenetic ground state of pluripotency. Cell Stem Cell 13, 351-359 (2013).
40. Habibi, E. et al. Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells. Cell Stem Cell 13, 360-369 (2013).
41. Silva, S. S., Rowntree, R. K., Mekhoubad, S. & Lee, J. T. X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc. Natl Acad. Sci. USA 105, 4820-4825 (2008).
42. Yeom, Y. I. et al. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 122, 881-894 (1996).
43. Nichols, J. & Smith, A. Naive and primed pluripotent states. Cell Stem Cell 4, 487-492 (2009).
44. Vallot, C. et al. XACT, a long noncoding transcript coating the active X chromosome in human pluripotent cells. Nat. Genet. 45, 239-241 (2013).
45. Shen, Y. et al. X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. Proc. Natl Acad. Sci. USA 105, 4709-4714 (2008).
46. Mekhoubad, S. et al. Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell 10, 595-609 (2012).
47. Vassena, R. et al. Waves of early transcriptional activation and pluripotency program initiation during human preimplantation development. Development 138, 3699-3709 (2011).
48. Bao, S. et al. Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells. Nature 461, 1292-1295 (2009).
49. Smith, Z. D. et al. A unique regulatory phase of DNA methylation in the early mammalian embryo. Nature 484, 339-344 (2012).
50. Okamoto, I. et al. Eutherian mammals use diverse strategies to initiate X-chromosome inactivation during development. Nature 472, 370-374 (2011).
51. Wianny, F. et al. Derivation and cloning of a novel Rhesus ES cell line stably expressing tau-GFP. Stem Cells 26, 1444-1453 (2008).
52. Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (Oxford, England) 4, 249-264 (2003).
53. Heider, A. & Alt, R. virtualArray: a R/bioconductor package to merge raw data from different microarray platforms. BMC Bioinformatics 14, 75 (2013).
54. Gu, H. et al. Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling. Nat. Protoc. 6, 468-481 (2011).